Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 2,580,000 shares, a drop of 7.9% from the August 15th total of 2,800,000 shares. Based on an average daily volume of 223,700 shares, the days-to-cover ratio is currently 11.5 days. Approximately 7.1% of the company’s shares are short sold.
Astrana Health Price Performance
Shares of ASTH opened at $55.11 on Tuesday. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.62. The firm has a market cap of $3.09 billion, a price-to-earnings ratio of 41.75, a PEG ratio of 1.85 and a beta of 1.20. Astrana Health has a 52 week low of $28.86 and a 52 week high of $56.25. The stock has a 50 day moving average of $48.54 and a 200-day moving average of $43.10.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The company had revenue of $486.30 million for the quarter, compared to analysts’ expectations of $440.68 million. During the same period in the prior year, the company earned $0.28 earnings per share. The firm’s revenue was up 39.7% compared to the same quarter last year. As a group, analysts forecast that Astrana Health will post 1.33 EPS for the current year.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on ASTH
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- What is Insider Trading? What You Can Learn from Insider Trading
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Calculate Return on Investment (ROI)
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Profitably Trade Stocks at 52-Week Highs
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.